Clinical Trial Update: Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing the anesthetic efficacy of 2% mepivacaine versus 4% articaine in symptomatic irreversible pulpitis is in progress with unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Irreversible Pulpitis

Drugs mentioned

• 2% mepivacaine (mepivacaine)
• 4% articaine (articaine)

Snippet

Sponsor: Cairo University | Conditions: Symptomatic Irreversible Pulpitis | Phase 2, Phase 3 | Status: UNKNOWN